Prathima Ka,
Ashok D
*a,
Sarasija Mb,
Prabhakar Sripadic,
Madhu Vemulac,
Venkata S. Komarrajud,
Biswajit Goraid and
Shyam Prakashd
aDepartment of Chemistry, Osmania University, Hyderabad, India. E-mail: ashokdou@gmail.com
bDepartment of Chemistry, Satavahana University, Karimnagar, Telangana, India 505001
cAnalytical Chemistry & Mass Spectrometry Division, CSIR – Indian Institute of Chemical Technology, India
dDepartment of Laboratory Medicine, All India Institute of Medical Sciences, India
First published on 16th November 2018
A series of novel hybrid molecular entities incorporating various spiro chromanone scaffolds onto the benzannulated oxepine core moiety were synthesised using allylation, Claisen rearrangement, Kabbe condensation and Ring Closing Metathesis (RCM) as a key step. During the synthesis we found that the nitrogen functionality in the substrate influences significantly the catalyst load due to electronic effects. Several iterations have been carried out to achieve complete conversion to products 6a–6e.
Spiro chromanones too are known to be bio-active molecules with activities ranging from anti-inflammatory, anti-cancer, anti-bacterial and anti-fungal properties.
Spiro-heterocycles in general have a wide range of biological properties11–15 like spiro oxindoles have antitumor and antibiotic activity. Aza spiro cyclic compounds too are important medicinally and have been used to treat depression, anxiety and pain.12 Likewise, oxepines are structurally important motifs in many natural products and constitute the core structure of biologically active molecules. We envisioned that combination of both these important frameworks i.e. the spiro chromanone and oxepine will provide a novel and unprecedented scaffold. Oxepines are medium sized heterocycles and can be constructed by three distinct approaches viz intramolecular cyclization, annulation and ring expansion. Apart from this they can also be constructed by Ring Closing Metathesis (RCM).16–18 It is thought to be a powerful CC bond forming reaction that occurs under very mild conditions. RCM of alkenes is indispensable to the synthesis of cyclic structures. It is a highly efficient reaction for the synthesis of carbocyclic, heterocyclic and fused ring frameworks and is used extensively in the synthesis of biologically active molecules. While most RCM reactions are performed using either Grubbs first-generation (G I) or Grubbs second-generation catalyst (G II) (Fig. 1), the latter has enjoyed wide application in organic synthesis due to its high functional group tolerance.19 However, in the case of metathetic cyclization, not every ring size is accessible with the same ease. The easiest reactions are those affording 5-to 7-membered rings with the entropic and enthalpic factors becoming less favourable with increasing size.
Exposure of dienes 3a–3h to G II under our optimized conditions (2 mol%, toluene, 70 °C) resulted in clean formation of the 4a–4h in good to excellent yields (65–91%) within 20–30 minutes (Scheme 2). 4i and 4j were also synthesised easily from their substrates 3i and 3j. Successful metathesis of above-mentioned spiro cyclic substrates to give good yields of benz-annulated oxepine spiro chromanones 4a–4j motivated us to explore the synthetic potential of G-II for our aza spiro cyclic substrates 5a–5j also. Thus, a series of products that could serve as precursors for the RCM was constructed in order to evaluate the scope of this reaction. In the first run, these substrates 5a–5j (0.18 mmol; Table 1) were stirred with G-II (2 mol%) in dry and degassed toluene at 70 °C maintaining the rest of the standard experimental protocol for metathesis reaction. Complete conversion to the products did not occur for 5a–5e (entries 1,5,8,11 and 13; Table 1) which is verified by GC-MS (Table 1). Metathesis at higher temperature of 110 °C keeping the catalyst load same, also did not lead to full conversion, (entry 9; Table 1). Substrates having either a protecting group or an electron withdrawing group have proceeded smoothly (entries 15–19; Table 1). In short, electron deficient aza spiro cycles are proven to be efficient substrates for RCM compared to those with excess electrons.20–22 The reason is attributed to the fact that the increased basicity on nitrogen is leading to the decomposition of catalyst, thus reducing availability at the site of action.23 When the reaction was monitored using a standard amount of 2 mol% of G II, carbene transfer must have occurred to a large extent at the basic nitrogen, where the ruthenium metal centre might have been stabilized by chelation. Such stabilization, in turn, could have reduced the concentration of the active catalyst in the reaction resulting in a negative impact on the rate of the metathesis.
Entry | Compound | Ra | Cat loading (mol%) | Temp | Yieldb | Conversion | Isomerd ratio (6a–6j) |
---|---|---|---|---|---|---|---|
a Substrate conc of 0.18 mmol.b Isolated yield.c Reaction monitored by GC-MS.d Isomer ratio as deduced from 1H NMR. | |||||||
1 | 5a | CH3 | 2 | 70 | >53c | ||
2 | 5a | CH3 | 7 | 110 | >95c | ||
3 | 5a | CH3 | 11 | 70 | >95c | ||
4 | 5a | CH3 | 15 | 70 | 78 | 5![]() ![]() |
|
5 | 5b | C3H7 | 2 | 70 | |||
6 | 5b | C3H7 | 3 | 70 | >95c | ||
7 | 5b | C3H7 | 4 | 70 | 61 | 20![]() ![]() |
|
8 | 5c | CH(CH3)2 | 2 | 70 | >55c | ||
9 | 5c | CH(CH3)2 | 2 | 110 | >40c | ||
10 | 5c | CH(CH3)2 | 3.5 | 70 | 75 | 5![]() ![]() |
|
11 | 5d | Bn | 2 | 70 | >97c | ||
12 | 5d | Bn | 3 | 70 | 56 | 2![]() ![]() |
|
13 | 5e | C2H4Ph | 2 | 70 | >95c | ||
14 | 5e | C2H4Ph | 4 | 70 | 85 | 20![]() ![]() |
|
15 | 5f | COMe | 2 | 70 | 82 | 0![]() ![]() |
|
16 | 5g | Bz | 2 | 70 | 87 | 2![]() ![]() |
|
17 | 5h | Cbz | 2 | 70 | 89 | 0![]() ![]() |
|
18 | 5i | CO2Et | 2 | 70 | 88 | 20![]() ![]() |
|
19 | 5j | Boc | 2 | 70 | 98 | 20![]() ![]() |
3a 1H NMR (500 MHz, CDCl3) δ 7.74 (d, 3J = 8.7 Hz, 1H), 6.53 (d, 3J = 8.7 Hz, 1H), 6.03 (ddt, J = 17.7, 10.3, 4.8 Hz, 1H), 5.95 (ddt, J = 14.2, 12.8, 6.4 Hz, 1H), 5.42 (dq, 3J = 17.2, 4J = 1.6, 2.0 Hz, 1H), 5.28 (dq, 3J = 10.6, 4J = 1.2 Hz, 1H), 5.07 (dq, 3J = 17.0, 2.0, 4J = 1.6 Hz, 1H), 4.97 (dq, 3J = 9.9, 2.0, 4J = 1.3 Hz, 1H), 4.60 (dt, J = 4.8, 1.6 Hz, 2H), 3.45 (dt, J = 6.4, 1.3 Hz, 2H), 2.60 (s, 2H), 2.09–2.04 (m, 2H), 1.72–1.64 (m, 4H), 1.53–1.41 (m, 4H). 13C NMR (125 MHz, CDCl3) δ 210.2, 180.7, 176.5, 154.3, 151.0, 144.3, 135.7, 134.7, 133.4, 133.1, 123.3, 98.2, 87.3, 66.5, 53.2, 48.0, 45.8, 43.5, 39.9. MS (EI) LRMS: m/z 312, 269, 217 (100%), 175, 149, 97, 69, 55.
3b 1H NMR (400 MHz, CDCl3) δ 7.75 (d, 3J = 8.7 Hz, 1H), 6.53 (d, 3J = 8.7 Hz, 1H), 6.04 (ddt, J = 17.7, 10.3, 4.8 Hz, 1H), 4 (ddt, J = 14.2, 12.8, 6.4 Hz, 1H), 5.42 (dq, 3J = 17.2, 2.0, 4J = 1.6 Hz, 1H), 5.29 (dq, 3J = 10.6, 2.0, 4J = 1.2 Hz, 1H), 5.09 (dq, 3J = 17.0, 2.0, 4J = 1.6 Hz, 1H), 5.08–4.94 (m, 1H), 4.61 (dt, J = 4.8, 1.6 Hz, 2H), 3.46 (*3.42, dt, J = 6.4, 1.3 Hz, 2H), 2.60 (*2.76, s, 2H), 2.12–1.91 (m, 2H), 1.76–1.61 (m, 2H), 1.54–1.32 (m, 5H), 0.95–0.92 (m, 3H). 13C NMR (100 MHz, CDCl3) δ 191.9, 162.4, 158.1, 136.0, 132.7, 126.0, 117.4, 116.4, 115.0, 114.6, 115.1, 105.0, 104.9, 81.0, 79.2, 68.9, 48.7, 34.6, 31.6, 29.7, 27.5, 22.3. MS (EI) LRMS: m/z 326, 269, 217, 175, 97, 69, 57, 44 (100%).
3c 1H NMR (400 MHz, CDCl3) δ 7.68 (d, 3J = 8.7 Hz, 1H), 6.46 (d, 3J = 8.7 Hz, 1H), 5.95 (ddt, J = 17.7, 10.3, 4.8 Hz, 1H), 5.86 (ddt, J = 14.2, 12.8, 6.4 Hz, 1H), 5.35 (dq, 3J = 17.2, 2.0, 4J = 1.6 Hz, 1H), 5.21 (dq, 3J = 10.6, 2.0, 4J = 1.2 Hz, 1H), 5.00 (dq, 3J = 17.0, 2.0, 4J = 1.6 Hz, 1H), 4.94–4.87 (m, 1H), 4.52 (dt, J = 4.8, 1.6 Hz, 2H), 3.38 (*3.35, dt, J = 6.4, 1.3 Hz, 2H), 2.53 (*2.68, s, 2H), 2.08–2.02 (*1.91–1.85 (m), m, 2H), 1.75–1.59 (m, 1H), 1.56–1.47 (m, 2H), 1.36–1.18 (m, 6H), 0.82 (t, 3H). 13C NMR (100 MHz, CDCl3) δ 190.9, 161.4, 157.1, 135.0, 131.7, 125.0, 116.3, 115.3, 114.1, 113.9, 103.9, 78.5, 67.9, 47.7, 37.3, 33.5, 28.5, 26.5, 26.3, 10.4. MS (EI) LRMS: m/z 340, 299, 269, 217, 175, 149, 97, 69, 57, 41 (100%).
3d 1H NMR (400 MHz, CDCl3) δ 7.68 (d, 3J = 8.7 Hz, 1H), 6.46 (d, 3J = 8.7 Hz, 1H), 5.97 (ddt, J = 17.7, 10.3, 4.8 Hz, 1H), 5.86 (ddt, J = 14.2, 12.8, 6.4 Hz, 1H), 5.34 (dq, 3J = 17.2, 2, 4J = 1.6 Hz, 1H), 5.21 (dq, 3J = 10.6, 2.0, 4J = 1.2 Hz, 1H), 5.00 (dq, 3J = 17.0, 2.0, 4J = 1.6 Hz, 1H), 4.94–4.86 (m, 1H), 4.53 (dt, J = 4.8, 1.6 Hz, 2H), 3.38 (*3.35, dt, J = 6.4, 1.3 Hz, 2H), 2.52 (*2.68, s, 2H), 2.08–2.01 (*1.89–1.84 (m), m, 2H), 1.73–1.47 (m, 2H), 1.36–1.10 (m, 9H), 0.82 (td, 3H). 13C NMR (100 MHz, CDCl3) δ 192.0, 162.4, 158.1, 136.0, 132.7, 126.0, 117.4, 116.3, 114.9, 104.9, 79.5, 68.9, 48.7, 39.2, 36.3, 34.6, 28.2, 27.8, 27.5, 27.3, 19.9, 14.3. MS (EI) LRMS: m/z 354, 269, 217 (100%), 175, 149, 91, 41 (90%).
3e 1H NMR (400 MHz, CDCl3) δ 7.68 (d, 3J = 8.7 Hz, 1H), 6.46 (d, 3J = 8.7 Hz, 1H), 5.97 (ddt, J = 17.7, 10.3, 4.8 Hz, 1H), 5.87 (ddt, J = 14.2, 12.8, 6.4 Hz, 1H), 5.35 (dq, 3J = 17.2, 2.0, 4J = 1.6 Hz, 1H), 5.21 (dq, 3J = 10.6, 2.0, 4J = 1.2 Hz, 1H), 5.00 (dq, 3J = 17.0, 2.0, 4J = 1.6 Hz, 1H), 4.94–4.86 (m, 1H), 4.54 (dt, J = 4.8, 1.6 Hz, 2H), 3.39 (*3.35, dt, J = 6.4, 1.3 Hz, 2H), 2.53 (*2.68, s, 2H), 2.08–2.01 (*1.89–1.84, m, 2H), 1.73–1.56 (m, 2H), 1.37–1.10 (m, 13H), 0.81 (td, 3H). 13C NMR (100 MHz, CDCl3) δ 192.0, 162.4, 158.1, 136.0, 132.7, 126.0, 117.4, 114.9, 104.9, 79.6, 68.9, 48.7, 36.9, 36.6, 34.6, 32.1, 27.8, 27.5, 26.5, 22.6, 14.0. MS (EI) LRMS: m/z 382, 341, 269, 217 (100%), 175, 149, 43, 41 (100%).
3f 1H NMR (400 MHz, CDCl3) δ 7.78 (d, 3J = 8.7 Hz, 1H), 7.34–7.21 (m, 5H), 6.56 (d, 3J = 8.7 Hz, 1H), 6.09–5.96 (m, 2H), 5.43 (dq, 3J = 17.2, 2.0, 4J = 1.6 Hz, 1H), 5.30 (dq, 3J = 10.6, 2.0, 4J = 1.2 Hz, 1H), 5.09 (dq, 3J = 17.0, 2.0, 4J = 1.6 Hz, 1H), 5.01 (dq, 3J = 9.9, 2.0, 4J = 1.3 Hz, 1H), (m, 1H), 4.62 (dt, J = 5.0, 1.5 Hz, 2H), 3.55 (dt, J = 6.2, 1.5 Hz, 2H), 2.67 (*2.91, s, 2H), 2.57 (tt, 1H), 2.31–2.13 (m, 2H), 1.97 (qd, 2H), 1.78–1.72 (m, 2H), 1.52 (dd, 2H). 13C NMR (100 MHz, CDCl3) δ 191.7, 162.5, 158.0, 146.6, 136.0, 132.7, 128.4, 126.8, 126.1, 117.4, 116.3, 115.0, 105.1, 78.8, 69.0, 48.7, 43.3, 34.9, 28.8, 27.4. MS (EI) LRMS: m/z 388, 360 (98%), 241 (100%), 189, 91, 77.
3g 1H NMR (400 MHz, CDCl3) δ 7.73 (d, 3J = 8.5 Hz, 1H), 6.68 (d, 3J = 8.5, 1H), 5.91 (pt, 3J = 5.7 2.0 Hz, 1H), 5.58 (dhpt, J = 11.2, 1.7 Hz, 1H), 4.64–4.61 (m, 2H), 4.01–3.93 (m, 4H), 3.59–3.57 (m, 2H), 2.67 (s, 2H), 2.14–2.09 (m, 2H), 1.91 (td, 2H), 1.78–1.71 (m, 2H), 1.64 (brd, 2H). 13C NMR (125 MHz, CDCl3) δ 209.7, 180.8, 176.2, 154.1, 150.9, 144.4, 135.8, 133.3, 126.3, 123.5, 97.1, 87.3, 82.7, 82.5, 65.9, 50.7, 48.5, 45.8. MS (EI) LRMS: m/z 330, 231, 177, 99 (100%), 86.
3h 1H NMR (400 MHz, CDCl3) δ 7.68 (d, 3J = 8.7 Hz, 1H), 6.47 (d, 3J = 8.7 Hz, 1H), 5.95 (ddt, J = 17.2, 10.3, 4.8 Hz, 1H), 5.85 (ddt, J = 14.2, 12.8, 6.4 Hz, 1H), 5.34 (dq, 3J = 17.2, 2.0, 4J = 1.6 Hz, 1H), 5.21 (dq, 3J = 10.3, 2.0, 4J = 1.2 Hz, 1H), 4.97 (dq, 3J = 17.0, 2.0, 4J = 1.6 Hz, 1H), 4.90 (dq, 3J = 9.9, 2.0, 4J = 1.3 Hz, 1H), 4.53 (dt, J = 4.8, 1.6 Hz, 2H), 3.46 (s, 2H), 3.38 (s, 4H), 2.56 (s, 2H), 1.96 (t, 4H), 1.78–1.71 (m, 2H), 1.56 (td, 2H), 0.89 (s, 6H). 13C NMR (100 MHz, CDCl3) δ 190.4, 161.5, 156.9, 134.8, 131.6, 125.1, 116.4, 115.4, 113.9, 104.2, 95.8, 78.2, 69.1, 69.0, 67.9, 46.6, 30.0, 29.1, 26.4, 21.6. MS (EI) LRMS: m/z 412, 217, 141 (100%), 128, 69.
3i 1H NMR (400 MHz, CDCl3) δ 7.76 (d, 3J = 8.7 Hz, 1H), 6.54 (d, 3J = 8.7 Hz, 1H), 6.03 (ddt, J = 17.7, 10.3, 4.8 Hz, 1H), 5.90 (ddt, J = 14.2, 12.8, 6.4 Hz, 1H), 5.42 (dq, 3J = 17.2, 2.0, 4J = 1.6 Hz, 1H), 5.29 (dq, 3J = 10.6, 2.0, 4J = 1.2 Hz, 1H), 5.01 (dq, 3J = 17.0, 2.0, 4J = 1.6 Hz, 1H), 4.94 (dq, 3J = 9.9, 2.0, 4J = 1.3 Hz, 1H), 4.60 (dt, J = 4.8, 1.6 Hz, 2H), 3.39 (dt, J = 6.4, 1.3 Hz, 2H), 2.77 (s, 2H), 2.09–2.03 (m, 2H), 1.91–1.83 (m, 2H), 1.76–1.67 (m, 2H), 1.65–1.58 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 191.7, 162.1, 159.0, 136.0, 132.7, 126.1, 117.3, 116.5, 115.3, 114.5, 105.1, 90.0, 68.8, 46.6, 37.4, 27.2, 23.8. MS (EI) LRMS: m/z 298, 269, 217 (100%), 175, 149, 91, 69.
3j 1H NMR (400 MHz, CDCl3) δ 7.73 (d, 3J = 8.7 Hz, 1H), 6.52 (d, 3J = 8.7 Hz, 1H), 6.03 (ddt, J = 17.7, 10.3, 4.8 Hz, 1H), 5.93 (ddt, J = 14.2, 12.8, 6.4 Hz, 1H), 5.41 (dq, 3J = 17.2, 2.0, 4J = 1.6 Hz, 1H), 5.28 (dq, 3J = 10.6, 2.0, 4J = 1.2 Hz, 1H), 5.05 (dq, 3J = 17.0, 2.0, 4J = 1.6 Hz, 1H), 4.96 (dq, 3J = 9.9, 2.0, 4J = 1.3 Hz, 1H), 4.59 (dt, J = 4.8, 1.6 Hz, 2H), 3.44 (dt, J = 6.4, 1.3 Hz, 2H), 2.66 (s, 2H), 2.13–2.03 (m, 2H), 1.77–1.63 (m, 4H), 1.59–1.51 (m, 4H), 1.47–1.38 (m, 2H)·13C NMR (100 MHz, CDCl3) δ 191.9, 162.3, 158.5, 136.0, 132.7, 125.9, 117.3, 116.4, 115.1, 114.7, 104.9, 84.2, 68.9, 48.7, 38.4, 29.3, 27.4, 22.0. MS (EI) LRMS: m/z 326, 269, 217 (100%), 175, 149, 91, 55.
5a1H NMR (400 MHz, CDCl3) δ 7.69 (d, 3J = 8.7 Hz, 1H), 6.48 (d, 3J = 8.7 Hz, 1H), 5.99 (ddt, J = 14.3, 10.3, 5.0 Hz, 1H), 5.90 (ddt, J = 21.0, 9.3, 3.0 Hz, 1H), 5.37 (dq, 3J = 17.0, 2.0, 4J = 1.7 Hz, 1H), 5.20 (dq, 3J = 10.7, 2.0, 4J = 1.2 Hz, 1H), 5.02 (dq, 3J = 17.0, 2.0, 4J = 1.5 Hz, 1H), 4.93 (dq, 3J = 10.0, 2.0, 4J = 1.2 Hz, 1H), 4.52 (dt, J = 5.0, 1.5 Hz, 2H), 3.39 (dt, J = 6.2, 1.5 Hz, 2H), 2.57 (s, 2H), 2.50 (td, 2H), 2.36 (td, 2H), 2.24 (s, 3H), 1.99 (brd, 2H), 1.78–1.71 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 190.2, 161.5, 156.8, 134.8, 131.6, 125.1, 116.4, 115.3, 114.0, 104.2, 67.9, 49.8, 45.0, 33.4, 26.4. MS (EI) LRMS: m/z 327, 326, 175, 110, 109, 96, 70 (100%).
5b 1H NMR (400 MHz, CDCl3) δ 7.69 (d, 3J = 8.7 Hz, 1H), 6.48 (d, 3J = 8.7 Hz, 1H), 6.03 (ddt, J = 14.3, 10.3, 5.0 Hz, 1H), 5.94 (ddt, J = 21.0, 9.3, 3.0 Hz, 1H), 5.42 (dq, 3J = 17.0, 2.0, 4J = 1.7 Hz, 1H), 5.29 (dq, 3J = 10.7, 2.0, 4J = 1.2 Hz, 1H), 5.06 (dq, 3J = 17.0, 2.0, 4J = 1.5 Hz, 1H), 4.99 (dq, 3J = 10.0, 2.0, 4J = 1.2 Hz, 1H), 4.60 (dt, J = 5.0, 1.5 Hz, 2H), 3.47 (dt, J = 6.2, 1.5 Hz, 2H), 2.58 (s, 2H) 2.39 (td, 3H), 2.25 (*t, d, 2H), 1.96 (brd, 2H), 1.78–1.71 (m, 4H), 1.42 (sxt, 2H), 0.85 (t, 3H). 13C NMR (100 MHz, CDCl3) δ 190.3, 161.5, 156.8, 134.9, 131.6, 125.1, 116.4, 114.0, 104.2, 76.8, 67.9, 59.6, 47.8, 33.4, 26.4, 19.1, 10.9. MS (EI) LRMS: m/z 355, 326 (100%), 110, 98, 70.
5c 1H NMR (400 MHz, CDCl3) δ 7.76 (d, 3J = 8.7 Hz, 1H), 6.55 (d, 3J = 8.7 Hz, 1H), 6.03 (ddt, J = 12.8, 10.3, 5.0 Hz, 1H), 5.94 (ddt, J = 16.3, 10.0, 3.7 Hz, 1H), 5.42 (dq, 3J = 17.0, 2.0, 4J = 1.7 Hz, 1H), 5.29 (dq, 3J = 10.7, 2.0, 4J = 1.5 Hz, 1H), 5.06 (dq, 3J = 17.0, 2, 4J = 1.5 Hz, 1H), 4.99 (dq, 3J = 10.0, 2.0, 4J = 1.2 Hz, 1H), 4.60 (dt, J = 5.0, 1.5 Hz, 2H), 3.47 (dt, J = 6.2, 1.5 Hz, 2H), 2.77 (hpt, 1H), 2.65 (s, 2H) 2.64–2.56 (m, 4H), 2.06 (brd, 2H), 1.77–1.70 (m, 2H), 1.07 (d, 6H).·13C NMR (100 MHz, CDCl3) δ 191.3, 162.5, 157.8, 135.9, 132.6, 126.1, 120.4, 118.3, 117.5, 116.3, 114.9, 105.2, 3.9, 78.0, 69.0, 54.6, 47.7, 44.0, 34.6, 33.3, 27.9, 27.4, 24.8, 21.5, 18.3. MS (EI) LRMS: m/z 355, 340 (100%), 284, 124, 56, 41.
5d 1H NMR (400 MHz, CDCl3) δ 7.75 (d, 3J = 8.7 Hz, 1H), 7.31 (s, 5H), 6.54 (d, 3J = 8.7 Hz, 1H), 6.04 (ddt, J = 17.1, 10.5, 5.0 Hz, 1H), 5.94 (ddt, J = 14.7, 12.7, 6.2 Hz, 1H), 5.40 (dq, 3J = 17.3, 2.0, 4J = 1.5 Hz, 1H), 5.28 (dq, 3J = 10.0, 2.0, 4J = 1.2 Hz, 1H), 5.08 (dq, 3J = 17.3, 2.0, 4J = 1.5 Hz, 1H), 5.01 (dq, 3J = 10.0, 2.0, 4J = 1.2 Hz, 1H), 4.60 (dt, J = 4.7, 1.7 Hz, 2H), 3.55 (s, 2H), 3.44 (d, 2H), 2.64 (s, 2H) 2.63–2.60 (m, 2H), 2.46 (t, 2H), 2.04 (d, 2H), 1.76–1.70 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 191.3, 162.5, 157.9, 132.6, 129.2, 127.1, 128.2, 127.1, 126.1, 138.0, 117.5, 116.4, 115.0, 105.2, 77.9, 69.0, 63.1, 48.7, 47.7, 34.5, 27.4. MS (EI) LRMS: m/z 403, 402, 185, 146, 91 (100%), 69.
5e 1H NMR (400 MHz, CDCl3) δ 7.78 (d, 3J = 8.7 Hz, 1H), 7.40 (s, 5H), 6.56 (d, 3J = 8.7 Hz, 1H), 6.03 (ddt, J = 14.1, 10.5, 5.0 Hz, 1H), 5.97 (ddt, J = 16.3, 9.2, 3.0 Hz, 1H), 5.42 (dq, 3J = 17.0, 2.0, 4J = 1.7 Hz, 1H), 5.31 (dq, 3J = 10.7, 2.0, 4J = 1.2 Hz, 1H), 5.06 (dq, 3J = 17.0, 2.0, 4J = 1.5 Hz, 1H), 5.00 (dq, 3J = 10.0, 2.0, 4J = 1.2 Hz, 1H), 4.62 (dt, J = 5.0, 1.5 Hz, 2H), 3.49 (dt, J = 6.2, 1.5 Hz, 2H), 2.84–2.75 (m, 4H), 2.67 (s, 2H) 2.54 (t, 2H), 2.07 (d, 2H), 1.81–1.63 (m, 4H). 13C NMR (100 MHz, CDCl3) δ 190.2, 161.5, 156.8, 139.2, 134.8, 131.6, 127.4, 127.6, 125.0, 116.4, 114.0, 115.3, 104.2, 76.7, 67.9, 59.4, 47.8, 46.7, 33.4, 32.7, 26.4. MS (EI) LRMS: m/z 417, 327, 326 (100%), 110.
5f 1H NMR (400 MHz, CDCl3) δ 7.71 (d, 3J = 8.7 Hz, 1H), 6.52 (d, 3J = 8.7 Hz, 1H), 5.99 (ddt, J = 17.1, 10.5, 5.0 Hz, 1H), 5.85 (ddt, J = 14.7, 12.7, 6.2 Hz, 1H), 5.37 (dd, J = 17.0, Hz, 1H), 5.23 (dd, J = 10.5, Hz, 1H), 4.95–4.90 (m, 2H), 4.54 (d, 2H), 4.33 (brd, 1H) 3.60–3.52 (m, 1H), 3.44 (d, 1H), 3.39 (d, 2H), 2.99 (t, 1H), 2.59 (s, 2H), 2.03 (s, 3H), 1.57–1.47 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 190.2, 169.1, 161.6, 158.0, 135.4, 126.5, 114.4, 114.4, 113.4, 110.0, 77.8, 47.5, 42.0, 37.1, 34.7, 34.0, 29.7, 27.2, 21.3. MS (EI) LRMS: m/z 355, 217, 175, 81, 69 (100%).
5g 1H NMR (400 MHz, CDCl3) δ 7.78 (d, 3J = 8.7 Hz, 1H), 7.40 (s, 5H), 6.58 (d, 3J = 8.7 Hz, 1H), 6.06 (ddt, J = 17.1, 10.5, 5.0 Hz, 1H), 5.95 (ddt, J = 15.7, 10.0, 3.7 Hz, 1H), 5.44 (dq, 3J = 17.3, 2.0, 4J = 1.5 Hz, 1H), 5.31 (dq, 3J = 10.5, 2.0, 4J = 1.5 Hz, 1H), 5.05–4.99 (m, 2H), 4.61 (dt, J = 5.0, 1.5 Hz, 2H), 4.52 (brs, 1H), 3.60 (brs, 1H), 3.48 (dt, J = 6.2, 1.5 Hz, 3H), 3.28 (brs, 1H), 2.68 (s, 2H), 2.18 (brd, 2H), 1.80–1.67 (m, 1H), 1.61–1.39 (m, 1H). 13C NMR (100 MHz, CDCl3) δ 190.3, 170.4, 162.7, 157.4, 135.9, 132.5, 129.7, 126.8, 126.8, 126.3, 115.0, 16.2, 114.8, 105.6, 77.8, 69.1, 47.7, 27.4. MS (EI) LRMS: m/z 417, 376, 217, 175, 105 (100%), 77.
5h 1H NMR (400 MHz, CDCl3) δ 7.77 (d, 3J = 8.7 Hz, 1H), 7.35 (s, 5H), 6.58 (d, 3J = 8.7 Hz, 1H), 6.02 (ddt, J = 17.1, 10.5, 5.0 Hz, 1H), 5.91 (ddt, J = 14.7, 12.7, 6.2 Hz, 1H), 5.44 (dq, 3J = 17.3, 2, 4J = 1.5 Hz, 1H), 5.39 (dq, 3J = 10.5, 2.0, 4J = 1.2 Hz, 1H), 5.13 (s, 2H), 4.99–4.96 (m, 2H), 4.61 (dt, J = 5.0, 1.5 Hz, 2H), 4.00 (brs, 2H), 3.46 (d, 2H), 3.26 (brs, 2H), 2.65 (s, 2H), 2.03 (brs, 2H), 1.61 (brs, 2H). 13C NMR (100 MHz, CDCl3) δ 190.6, 162.6, 157.5, 155.2, 136.6, 135.8, 132.5, 128.5, 127.9, 126.3, 117.6, 116.3, 115.0, 105.5, 69.0, 67.2, 47.8, 39.5, 29.7, 27.4. MS (EI) LRMS: m/z 447, 357, 356, 312, 217, 215, 175, 92, 91 (100%), 44, 41.
5i 1H NMR (400 MHz, CDCl3): δ 7.78 (d, 3J = 8.7 Hz, 1H), 6.58 (d, 3J = 8.7 Hz, 1H), 6.07 (ddt, J = 17.1, 10.5, 5.0 Hz, 1H), 5.93 (ddt, J = 14.7, 12.7, 6.2 Hz, 1H), 5.44 (dq, 3J = 17.3, 2.0, 4J = 1.5 Hz, 1H), 5.31 (dq, 3J = 10.5, 2.0, 4J = 1.5 Hz, 1H), 5.04–4.97 (m, 2H), 4.61 (dt, J = 5.0, 1.5 Hz, 2H), 4.13 (q, J = 7.0, 2H) 3.93 (brs, 2H), 3.47 (dt, J = 6.0, 1.2 Hz, 2H), 3.25 (brt, 2H) 2.65 (s, 2H), 2.02 (d, 2H), 1.64–1.56 (m, 2H), 1.24 (t, J = 7.0, 3H). 13C NMR (100 MHz, CDCl3) δ 190.6, 162.6, 157.5, 155.4, 135.8, 132.5, 126.3, 117.6, 116.3, 115.0, 105.5, 77.8, 69.0, 61.4, 47.8, 39.3, 34.1, 29.7, 27.4, 14.6. MS (EI) LRMS: m/z 385, 344, 217, 175 (100%), 69.
5j 1H NMR (400 MHz, CDCl3) δ 7.77 (d, 3J = 8.7 Hz, 1H), 6.57 (d, 3J = 8.7 Hz, 1H), 6.04 (ddt, J = 17.1, 10.5, 5.0 Hz, 1H), 5.92 (ddt, J = 14.7, 12.7, 6.2 Hz, 1H), 5.42 (dq, 3J = 17.3, 2.0, 4J = 1.7 Hz, 1H), 5.30 (dq, 3J = 10.5, 2.0, 4J = 1.5 Hz, 1H), 5.03–4.96 (m, 2H), 4.61 (dt, J = 5.0, 1.5 Hz, 2H), 3.89 (brs, 2H), 3.47 (dt, J = 6.2, 1.5 Hz, 2H), 3.20 (brs, 2H) 2.65 (s, 2H), 2.04 (d, 2H), 1.60 (s, 2H), 1.46 (s, 9H). 13C NMR (100 MHz, CDCl3) δ 190.8, 162.6, 157.6, 154.7, 135.8, 132.5, 126.2, 117.6, 116.3, 115.0, 105.5, 79.7, 77.9, 69.0, 47.8, 28.4, 27.4. MS (EI) LRMS: m/z 413357, 312, 217, 175, 96, 57 (100%).
4a 1H NMR (400 MHz, CDCl3) δ 7.72 (*7.67, d, 3J = 8.5 Hz, 1H), 6.66 (*6.58, d, 3J = 8.5, 1H), 5.92{*6.08 (dt, J = 12.3, 4.4 Hz), pt, 3J = 5.5, 2.0 Hz, 1H}, 5.58 (dhpt, J = 11.2, 1.7 Hz, 1H), 4.65–4.61{*4.30 (t, J = 4.8 Hz), m, 2H}, 3.61–3.59 (m, 2H), 2.64 (s, 2H), 2.02 (brd, 2H), 1.71–1.59 (m, 4H), 1.57–1.51 (m, 2H), 1.47–1.41 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 210.4, 183.7, 175.3, 145.8, 144.9, 144.2, 142.1, 135.6, 133.0, 98.5, 88.7, 66.5, 53.0, 48.0, 43.5, 40.7, 39.9. MS (EI) LRMS: m/z 284, 241, 189 (100%); HRMS (EI): m/z calcd for C19H24O2 is 284.1776; found: 284.1775.
4b 1H NMR (400 MHz, CDCl3) δ 7.72 (d, 3J = 8.5 Hz, 1H), 6.67 (d, 3J = 8.5, 1H), 5.90 (pt, 3J = 5.7 2.0 Hz, 1H), 5.58 (dhpt, J = 11.2, 1.7 Hz, 1H), 4.64–4.61 (m, 2H), 3.60–3.55 (m, 2H), 2.62 (*2.77, s, 2H), 2.05 (m, 2H), 1.74–1.66 (m, 2H), 1.59–1.35 (m, 4H), 1.28–1.12 (m, 1H), 0.97 (m, 3H). 13C NMR (100 MHz, CDCl3) δ 192.1, 165.3, 156.8, 136.0, 127.5, 126.5, 125.9, 123.8, 120.6, 118.3, 117.4, 114.6, 79.5, 70.4, 48.6, 34.7, 31.5, 29.9, 25.1, 21.4, 22.4, 22.3. MS (EI) LRMS: m/z 298, 255, 205, 203 (100%), 189, 131, 69, 41; HRMS (EI): m/z calcd for C19H22O3 is 298.1568; found: 298.1550.
4c 1H NMR (400 MHz, CDCl3) δ 7.72 (d, 3J = 8.5 Hz, 1H), 6.66 (d, 3J = 8.5, 1H), 5.90{*6.05 (dd, J = 12.2, 4.5 Hz), pt, 3J = 5.7 2.0 Hz, 1H}, 5.58 (dhpt, J = 11.2, 1.7 Hz, 1H), 4.63–4.62 (*4.85–4.82, m, 2H), 3.59–3.57 (m, 2H), 2.62 (*2.76, s, 2H), 2.16–2.10 (m, 2H), 1.62–1.56 (m, 2H), 1.40–1.19 (m, 7H), 0.90 (t, 3H). 13C NMR (100 MHz, CDCl3) δ 192.2, 165.3, 156.8, 127.5, 126.5, 125.9, 123.8, 117.4, 114.7, 79.9, 70.4, 48.6, 38.1, 34.4, 29.6, 27.4, 22.3, 11.3. MS (EI) LRMS: m/z 312, 242, 241, 190, 189 (100%), 160, 77, 41; HRMS (EI): m/z calcd for C20H24 O3 is 312.1725; found: 312.1695.
4d 1H NMR (400 MHz, CDCl3) δ 7.72 (d, 3J = 8.5 Hz, 1H), 6.66 (d, 3J = 8.5, 1H), 5.91 (pt, 3J = 5.7 2.0 Hz, 1H), 5.58 (dhpt, J = 11.2, 1.7 Hz, 1H), 4.64–4.61 (m, 2H), 3.60–3.55 (m, 2H), 2.62 (*2.76, s, 2H), 2.10 (brd, 2H), 1.62–1.57 (m, 3H), 1.37–1.22 (m, 8H), 0.90 (m, 3H). 13C NMR (100 MHz, CDCl3) δ 192.1, 165.3, 156.8, 127.5, 126.6, 125.9, 123.8, 117.4, 114.7, 79.9, 70.4, 48.6, 39.4, 36.1, 34.4, 27.9, 22.3, 20.3, 19.9, 14.3. MS (EI) LRMS: m/z 326, 255, 241 (99%), 190, 189 (100%), 149, 69, 57, 55, 43, 41; HRMS (EI): m/z calcd for C21H26O3 is 326.1881; found: 326.1863.
4e 1H NMR (400 MHz, CDCl3) δ 7.72 (d, 3J = 8.5 Hz, 1H), 6.58 (d, 3J = 8.5, 1H), 5.94 (pt, 3J = 5.7 2.0 Hz, 1H), 5.58 (dhpt, J = 11.2, 1.7 Hz, 1H), 4.64–4.61 (m, 2H), 3.60–3.55 (m, 2H), 2.61 (*2.76, s, 2H), 2.10 (brd, 2H), 1.62–1.58 (m, 2H), 1.36–1.22 (m, 13H), 0.89 (m, 3H). 13C NMR (100 MHz, CDCl3) δ 192.1, 165.3, 156.8, 127.5, 126.6, 125.9, 123.8, 117.4, 114.7, 79.9, 70.4, 48.6, 37.0, 36.4, 34.4, 32.1, 27.9, 26.5, 22.3, 14.0. MS (EI) LRMS: m/z 354, 283, 241 (100%), 231, 190, 189 (100%), 69, 55, 41; HRMS (EI): m/z calcd for C23H30O3 is 354.2194; found: 354.2200.
4f 1H NMR (400 MHz, CDCl3) δ 7.75 (d, 3J = 8.5 Hz, 1H), 7.35–7.29 (m, 2H), 7.24–7.20 (m, 3H), 6.69 (d, 3J = 8.5, 1H), 5.96 (*6.13 (dd, J = 12.2, 4.5 Hz), pt, 3J = 5.7, 2.0 Hz, 1H), 5.58 (dhpt, J = 11.2, 1.7 Hz, 1H), 4.65–4.62 (m, 2H), 3.70–3.68 (*3.59–3.56 (m), 2H), 2.69 (*2.91, s, 2H), 2.59 (tt, J = 12.5, 11.2, 4.0 Hz, 1H), 2.24 (brd, 2H), 1.98–1.84 (m, 2H), 1.82–1.71 (m, 2H), 1.54 (td, 2H). 13C NMR (100 MHz, CDCl3) δ 192.0, 165.4, 156.7, 146.5, 128.5, 127.7, 126.7, 126.0, 114.9, 79.2, 70.4, 48.5, 43.1, 34.7, 29.8, 28.8, 22.4. MS (EI) LRMS: m/z 360, 286, 241, 229, 189, 177, 149, 91, 86, 84, 69, 57, 49, 41; HRMS (EI): m/z calcd for C24H24O3 is 360.1725; found: 360.1700.
4g 1H NMR (400 MHz, CDCl3) δ 7.73 (d, 3J = 8.5 Hz, 1H), 6.68 (d, 3J = 8.5, 1H), 5.91 (pt, 3J = 5.7 2.0 Hz, 1H), 5.58 (dhpt, J = 11.2, 1.7 Hz, 1H), 4.64–4.61 (m, 2H), 4.01–3.93 (m, 4H), 3.59–3.57 (m, 2H), 2.67 (s, 2H), 2.14–2.09 (m, 2H), 1.91 (td, 2H), 1.78–1.71 (m, 2H), 1.64 (brd, 2H). 13C NMR (100 MHz, CDCl3) δ 191.5, 156.6, 127.4, 126.5, 126.0, 123.8, 117.2, 115.0, 107.9, 79.1, 70.4, 64.4, 64.3, 47.5, 32.2, 30.2, 22.3. MS (EI) LRMS: m/z 342, 269, 217, 189 (100%), 175, 99, 86, 84; HRMS (EI): m/z calcd for C20H22O5 is 342.1467; found: 342.1462.
4h 1H NMR (400 MHz, CDCl3) δ 7.73 (d, 3J = 8.5 Hz, 1H), 6.68 (d, 3J = 8.5, 1H), 5.91 (pt, 3J = 5.7 2.0 Hz, 1H), 5.56 (dhpt, J = 11.2, 1.7 Hz, 1H), 4.64–4.61 (m, 2H), 3.58–3.57 (m, 2H), 3.54 (s, 2H), 3.46 (s, 2H), 2.65 (s, 2H), 2.11–1.99 (m, 4H), 1.77–1.70 (m, 2H), 1.66–1.61 (m, 2H), 0.97 (s, 6H). 13C NMR (100 MHz, CDCl3) δ 191.5, 165.4, 156.7, 127.4, 126.6, 125.9, 123.8, 117.2, 114.9, 96.7, 79.5, 70.1, 47.6, 30.9, 30.2, 27.6, 22.4. MS (EI) LRMS: m/z 384, 298, 189, 141 (100%), 128, 84, 69; HRMS (EI): m/z calcd for C23H28O5 is 384.1936; found: 384.1933.
4i 1H NMR (400 MHz, CDCl3) δ 7.65 (*7.68, d, 3J = 8.5 Hz, 1H), 6.58 (*d, 3J = 8.5, 1H), 5.81{*5.95 (dt, J = 12.2, 3.7 Hz), pt, 3J = 5.5, 2.0 Hz, 1H}, 5.50{*4.77–4.74 (m), dhpt, J = 11.2, 1.7 Hz, 1H}, 4.56–4.52{*4.21 (t, J = 4.7 Hz), m, 2H}, 3.46–3.43{*4.12 (dd, J = 12.5, 1.7 Hz), m, 2H}, 2.71 (s, 2H), 2.03–1.97 (m, 2H), 1.83–1.73 (m, 2H), 1.71–1.63 (m, 2H), 1.60–1.51 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 192.3 (*191.5), 165.7 (*165.2), 159.8, 157.9, 130.7, 127.7 (*127.4), 126.7 (*126.1), 125.6, 124.0, 114.8, 113.6, 91.2 (*90.3), 82.5, 70.4 (*70.5), 46.4 (*46.2), 37.8, 37.4, 37.1, 23.8, 22.3. MS (EI) LRMS: m/z 270, 241, 189 (100%); HRMS (EI): m/z calcd for C17H18O3 is 270.1255; found: 270.1250.
4j 1H NMR (400 MHz, CDCl3) δ 7.71 (d, 3J = 8.5 Hz, 1H), 6.65 (d, 3J = 8.5, 1H), 5.91 (pt, 3J = 5.5, 2.0 Hz, 1H), 5.58 (dhpt, J = 11.2, 1.7 Hz, 1H), 4.64–4.61 (m, 2H), 3.60–3.58 (m, 2H), 2.68 (s, 2H), 2.43–2.40 (m, 1H), 2.12–2.07 (m, 2H), 1.91–1.85 (m, 1H), 1.76–1.63 (m, 3H), 1.61–1.52 (m, 3H), 1.49–1.40 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 192.1, 165.3, 157.2, 127.4, 126.6, 125.8, 123.6, 117.3, 114.5, 84.3, 70.4, 48.7, 38.2, 28.9, 22.5, 22.0. MS (EI) LRMS: m/z 298, 255, 241, 189 (100%), 134, 98, 84, 55. HRMS (EI): m/z calcd for C19H22O3 is 298.1568; found: 298.1558.
6a 1H NMR (400 MHz, CDCl3) δ 7.73 (*7.69, d, 3J = 8.5 Hz, 1H), 6.70 (*6.62, d, 3J = 8.5 Hz, 1H), 5.92{pt, 3J = 5.5, 2.2 Hz,*6.10 (dt, 3J = 12.0, 4.5 HZ), *6.39 (dt, J = 7.2, 1.7 Hz, 1H}, 5.59{dhpt, 3J = 11.2, 1.7 Hz, *4.90 (dt, 3J = 7.5, 4.5 Hz), *5.05–5.02 (m), 1H}, 4.65–4.62{m, *4.30 (t, 3J = 4.7 Hz), 2H}, 3.61–3.59 {m,*3.29–3.27 (m),*3.17–3.14 (m), 2H}, 2.68 (s, 4H), 2.38 (s, 4H), 2.10–1.98 (m, 3H), 1.75–1.79 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 191.3, 165.4, 127.6, 126.4, 126.0, 123.8, 117.37, 115.0, 70.4, 51.0, 46.1, 34.2, 29.6, 26.3, 22.4. MS (EI) LRMS: m/z 299, 110, 96, 81, 70, 69 (100%), 57, 55. HRMS (EI): m/z calcd for C18H21NO3 is 299.1521; found: 299.1519.
6b 1H NMR (400 MHz, CDCl3) δ 7.73 (*7.68, d, 3J = 8.5 Hz, 1H), 6.68 (*6.60, d, 3J = 8.5 Hz, 1H), 5.92{pt, 3J = 5.5, 2.0 Hz,*6.09 (dt, 3J = 12.0, 4.5 Hz), 1H}, 5.58{dhpt, 3J = 11.2, 1.7 Hz,*5.45–5.39 (m), 1H}, 4.66–4.61{m, *4.30 (t, 3J = 4.7 Hz), 2H}, 3.61–3.59 (m, 2H), 2.72–2.69 (m, 2H), 2.67 (s, 2H), 2.39–2.28 (m, 4H), 2.04 (d, 2H), 1.79–1.71 (m, 2H), 1.54 (sxt, J = 7.5, 2H), 0.91 (t, 3H).·13C NMR (100 MHz, CDCl3) 191.4, 165.4, 156.5, 127.5, 126.5, 126.0, 123.8, 117.4, 115.0, 78.2, 70.4, 60.7, 48.9, 34.2, 22.5, 20.1, 11.9. MS (EI) LRMS: m/z 327, 299, 198 (100%), 187, 110, 70. HRMS (EI): m/z calcd for C20H25NO3 is 327.1834; found: 327.1814.
6c 1H NMR (400 MHz, CDCl3) δ 7.73 (*7.68, d, 3J = 8.5 Hz, 1H), 6.68 (*6.62, d, 3J = 8.5 Hz, 1H), 5.91{pt, J = 5.7, 2.0 Hz, *6.09 (dt, 3J = 12.2, 4.5 HZ), 1H}, 5.58 (dhpt, 3J = 11.2, 1.7 Hz, 1H), 4.64–4.62{m, *4.30 (t, 3J = 5.0 Hz), 2H}, 3.63–3.59 (m, 2H), 2.76 (hpt, 1H), 2.70–2.68 (m, 1H), 2.66 (s, 2H), 2.66–2.63 (m, 1H), 2.55 (td, 2H), 2.05 (brd, 2H), 1.80–1.74 (m, 2H), 1.07 (d, 6H).·13C NMR (100 MHz, CDCl3) δ 191.5, 165.4, 156.5, 127.6, 126.4, 126.0, 123.8, 117.4, 115.0, 78.4, 70.4, 54.5, 47.7, 44.0, 34.5, 22.4, 18.2. MS (EI) LRMS: m/z 327, 313, 236, 98, 83, 71, 69, 57, 44 (100%). HRMS (EI): m/z calcd for C20H25NO3 is 327.1834; found: 327.1810.
6d 1H NMR (400 MHz, CDCl3) δ 7.72 (d, 3J = 8.7 Hz, 1H), 7.32 (s, 5H), 6.67 (d, 3J = 8.7 Hz, 1H), 5.87 (pt, J = 5.5, 2.0 Hz, 1H), 5.60 (dhpt, J = 11.2, 1.7 Hz, 1H), 4.64–4.61 (m, 2H), 3.56 (s, 4H), 2.65 (s, 4H), 2.38 (td, J = 11.5 Hz, 2H), 2.03 (brd, 2H), 1.80–1.68 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 191.5, 165.4, 156.6, 137.8, 129.2, 128.2, 127.5, 127.1, 126.5, 125.9, 123.8, 117.3, 115.0, 78.2, 70.4, 63.1, 48.7, 34.3, 22.5. MS (EI) LRMS: m/z 375, 189, 97, 91 (100%), 71, 69, 57. HRMS (EI): m/z calcd for C24H25NO3 is 375.1834; found: 375.1813.
6e 1H NMR (400 MHz, CDCl3) δ 7.73 (*7.68, d, 3J = 8.5 Hz, 1H), 7.31–7.26 (m, 3H), 7.24–7.19 (m, 2H), 6.67 (*6.61, d, 3J = 8.7 Hz, 1H), 5.93{pt, 3J = 5.5, 2.0 Hz,*6.38 (dt, 3J = 7.2, 1.5 HZ), 1H}, 5.57{dhpt, J = 11.2, 1.5 Hz, *5.43 (brs), 1H}, 4.64–4.62{m,*4.30 (t, 3J = 4.7 Hz), 2H}, 3.61–3.60{m, 2H, *3.66 (t, J = 7.0 Hz, 2H)}, 2.85–2.77 (m, 4H), 2.68 (s, 2H) 2.66–2.63 (m, 2H), 2.52–2.40 (m, 2H), 2.10 (brd, 2H), 1.81–1.73 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 191.4, 165.4, 156.5, 140.2, 131.0, 128.6, 128.4, 127.6, 126.4, 126.1, 126.0, 123.8, 119.7, 117.3, 115.0, 78.1, 70.4, 60.5, 49.0, 34.3, 33.7, 22.5. MS (EI) LRMS: m/z 389, 360, 359 (100%), 298, 110, 105, 91, 83, 71. HRMS (EI): m/z calcd for C25H27NO3 is 389.1990; found: 389.1989.
6f 1H NMR (400 MHz, CDCl3) δ 7.68 (*7.60, d, 3J = 8.5 Hz, 1H), 6.65 (*6.57, d, 3J = 8.7 Hz, 1H), 5.82{pt, 3J = 5.7, 2.0 Hz,*6.04, (dt, J = 12.0, 4.2 Hz), 1H}, 5.51{dhpt, J = 11.2, 1.5 Hz, *5.38–5.33 (m), 1H}, 4.58–4.55 (m, 2H), 4.37 (dp, J = 13.5, 2.0 Hz, 1H), 3.61 (dp, J = 13.5, 2.0 Hz, 1H), 3.52–3.51 (m, 2H), 3.36 (td, 1H), 2.92 (td, 1H), 2.61 (s, 2H), 2.04 (s, 5H), 1.54 (qd, 2H). 13C NMR (100 MHz, CDCl3) δ 190.6, 169.0, 165.6, 156.0, 131.6, 127.7, 126.1, 123.8, 117.1, 115.5, 114.2, 78.0, 70.4, 47.6, 42.0, 37.0, 34.4, 33.8, 22.4, 21.4. MS (EI) LRMS: m/z, 312, 214, 189 (100%), 160, 96, 91, 82, 55. HRMS (EI): m/z calcd for C20H25NO3 is 327.1834: found: 327.1831.
6g 1H NMR (400 MHz, CDCl3) δ 7.69 (*7.73, d, 3J = 8.7 Hz, 1H), 7.34 (s, 5H), 6.63{dt, J = 12.2, 1.7 Hz}, 6.64 (*6.71, d, 3J = 8.7 Hz, 1H), 6.19{dt, J = 12.2, 4.5 Hz, *5.92 (pt, J = 5.5, 2.0 Hz), 1H}, 5.59 (t, J = 4.7 Hz, 2H), 4.57 (s, 2H), 4.48 (brs, 1H), 3.53 (s, 2H), 3.22 (brd, 2H), 2.65 (s, 2H) 1.86–1.73 (m, 2H), 2.01–1.85 (m, 1H). 13C NMR (100 MHz, CDCl3) δ 190.2, 170.5, 166.0, 157.7, 142.7, 135.6, 131.7, 129.8, 128.5, 126.9, 126.1, 119.2, 116.0, 115.7, 114.2, 78.6, 70.4, 47.4, 34.1. MS (EI) LRMS: m/z 389, 229, 177, 149, 105 (100%). HRMS (EI): m/z calcd for C24H23NO4; found: 389.1600.
6h 1H NMR (400 MHz, CDCl3) δ = 7.74 (d, 3J = 8.5 Hz, 1H), 7.37–7.35 (m, 5H), 6.71 (d, 3J = 8.7 Hz, 1H), 5.91 (pt, 3J = 5.5, 2.0 Hz, 1H), 5.58 (dhpt, J = 11.2, 1.7 Hz, 1H), 5.13 (s, 2H), 4.64–4.62 (m, 2H), 4.02 (brs, 2H), 3.59 (m, 2H), 3.19 (brs, 2H), 2.67 (s, 2H), 2.06 (brs, 2H), 1.64–1.56 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 190.7, 165.6, 156.1, 155.2, 136.6, 128.5, 128.1, 127.9, 127.6, 126.2, 126.1, 123.7, 117.2, 115.4, 78.0, 70.4, 67.2, 47.7, 39.5, 33.9, 22.4. MS (EI) LRMS: m/z 419, 328 (100%), 284, 187, 91. HRMS (EI): m/z calcd for C25H25NO5 is 419.1732; found: 419.1750.
6i 1H NMR (400 MHz, CDCl3) δ 7.74 (*7.69, d, 3J = 8.5 Hz, 1H), 6.71 (*6.53, d, 3J = 8.7 Hz, 1H), 5.92{pt, 3J = 5.5, 2.0 Hz,*6.08 (dt, J = 12.2, 4.5 Hz), *6.37 (dt, J = 7.2, 2.0 Hz), 1H }, 5.60{dhpt, J = 11.2, 1.7 Hz, 1H}, 4.63{(dt, J = 7.5, 4.2 Hz), *4.96–4.83 (m), 2H}, 4.14 (q, J = 7.2 Hz, 2H), 3.97 (brs, 2H), 3.58–3.50{m, *3.68–3.63 (m), 2H}, 3.27–3.10 (m, 2H), 2.68 (s, 2H), 2.07 (brd, 2H), 1.62–1.57 (m, 2H), 1.25 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 189.8, 164.5, 155.2, 154.4, 126.6, 125.2, 125.1, 116.2, 114.3, 122.7, 77.1, 69.4, 60.5, 46.7, 38.3, 32.9, 21.4, 13.6. MS (EI) LRMS: m/z 357, 342, 189 (100%), 160. HRMS (EI): m/z calcd for C20 H23NO5 is 357.1576; found 357.1570.
6j 1H NMR (400 MHz, CDCl3) δ 7.69 (*7.61, d, 3J = 8.5 Hz, 1H), 6.64 (*6.54, d, 3J = 8.7 Hz, 1H), 5.83{pt, 3J = 5.7, 2.0 Hz, *6.04, (dt, J = 12.0, 4.2 Hz), 1H}, 5.50 (dhpt, J = 11.2, 1.5 Hz, 1H), 4.57–4.55 (m, 2H), 3.89 (brs, 2H), 3.52–3.50 (m, 2H), 3.06 (brs, 2H), 2.60 (s, 2H), 1.95 (brd, 2H), 1.64–1.52 (m, 2H), 1.39 (s, 9H). 13C NMR (100 MHz, CDCl3) δ 189.9, 164.5, 155.2, 153.6, 126.6, 125.3, 125.0, 122.7, 116.2, 114.3, 78.8, 77.1, 69.4, 46.7, 33.0, 27.4, 21.4. MS (EI) LRMS: m/z 385, 330, 329 (100%) 314, 189, 96. HRMS (EI): m/z calcd for C22H27NO5: 385.1889; found: 385.1900.
Footnote |
† Electronic supplementary information (ESI) available. See DOI: 10.1039/c8ra07920j |
This journal is © The Royal Society of Chemistry 2018 |